| abstract |
Formula (I): (Wherein the variable groups are as described herein) are provided for aryl substituted benzo [d] isothiazol-3-ylamine analogs. Such compounds are ligands that can be used to modulate specific receptor activity in vivo and in vitro, particularly for the treatment of diseases associated with pathological receptor activity in humans, pets and livestock. Useful. The present invention also provides pharmaceutical compositions and methods for treating such diseases using such compounds, as well as methods for using such ligands in receptor localization studies. |